XML 18 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments in Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 28, 2014
Investments, Debt and Equity Securities [Abstract]  
Investments in Cash Equivalents and Marketable Securities
Investments in Cash Equivalents and Marketable Securities
As of June 28, 2014 and December 31, 2013, cash equivalents and short-term investments were classified as available-for-sale. Cash equivalents had maturity dates of less than 90 days at the date acquired, and short-term investments had maturity dates of less than one year, from the date of purchase. All unrealized gains and losses on available-for-sale investments are included in Other comprehensive income (loss). The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at June 28, 2014 consisted of the following: 
At June 28, 2014
 
Cost
 
Net
unrealized
holding gains
 
Net
unrealized
holding losses
 
Fair
Value
Available-for-sale-included in cash equivalents:
 
 
 
 
 
 
 
 
Money market funds
 
$
111,934

 
$

 
$

 
$
111,934

Corporate debt securities
 
8,998

 

 

 
8,998

Available-for-sale-included in short-term marketable securities:
 
 
 
 
 
 
 
 
Corporate debt securities
 
8,981

 

 
(2
)
 
8,979

Long-term investments included in Other noncurrent assets, net:

 
 
 
 
 
 
 
 
Corporate debt securities
 
1,014

 

 

 
1,014

 
 
$
130,927

 
$

 
$
(2
)
 
$
130,925


The cost, net unrealized holding gains, net unrealized holding losses and fair value of available-for-sale investments by types and classes of security at December 31, 2013 consisted of the following: 
At December 31, 2013
 
Cost
 
Net
unrealized
holding gains
 
Net
unrealized
holding losses
 
Fair
Value
Available-for-sale-included in cash equivalents:
 
 
 
 
 
 
 
 
Money market funds and other
 
$
25,904

 
$

 
$

 
$
25,904

 
 
$
25,904

 
$

 
$

 
$
25,904


Investments are considered to be impaired when a decline in fair value is judged to be other-than-temporary. The Company employs a methodology that reviews specific securities in evaluating potential impairment of its investments. In the event that the cost of an investment exceeds its fair value, the Company evaluates, among other factors, the Company’s intent and ability to hold the investment and extent to which the fair value is less than cost; the financial health of and business outlook for the issuer; and operating and financing cash flow factors. During the three and six months ended June 28, 2014, the Company did not record any other-than-temporary impairments on its investments in cash equivalents.